Deepti  Jain net worth and biography

Deepti Jain Biography and Net Worth

Deepti Jain has served as a member of our board of directors since October 2021. Ms. Jain served as President of lngenioRX, the pharmacy benefit management division of Anthem, Inc. (NYSE: ANTM), a publicly-traded health benefits company, from January 2019 to December 2020. She served as Chief Operating Officer for Pharmacy Solutions for Anthem from 2014 to 2018. From 1998 to 2012, Ms. Jain held positions of increasing responsibility, including Senior Vice President & Chief Financial Officer of the Health Plan Division from 2010 to 2012, with Medco Health Solutions, Inc., a publicly ­ traded pharmacy benefits management company which was acquired by Express Scrip ls in April 2012. From April 2019 to November 2020, she served on the board of directors or the Pharmaceutical Care Management Association (PCMA), the national association representing America's pharmacy benefit managers. Ms. Jain currently serves on the Board or Directors of Tactile Systems Technology, Inc. (NASDAQ: TCMD), a Nasdaq publicly traded medical device corporation. Ms. Jain has a B.A. in Philosophy & Music from Dayanand Anglo Vedic College, India, an M.A. in English Literature from Guru Nanak Dev University, India, and an M.B.A., Finance & Investments from Baruch College, NYC.

What is Deepti Jain's net worth?

The estimated net worth of Deepti Jain is at least $85.58 thousand as of May 10th, 2024. Ms. Jain owns 31,235 shares of Treace Medical Concepts stock worth more than $85,584 as of December 4th. This net worth approximation does not reflect any other assets that Ms. Jain may own. Learn More about Deepti Jain's net worth.

How do I contact Deepti Jain?

The corporate mailing address for Ms. Jain and other Treace Medical Concepts executives is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. Treace Medical Concepts can also be reached via phone at 904-373-5940 and via email at [email protected]. Learn More on Deepti Jain's contact information.

Has Deepti Jain been buying or selling shares of Treace Medical Concepts?

Deepti Jain has not been actively trading shares of Treace Medical Concepts during the past quarter. Most recently, on Friday, May 10th, Deepti Jain bought 25,000 shares of Treace Medical Concepts stock. The stock was acquired at an average cost of $4.50 per share, with a total value of $112,500.00. Following the completion of the transaction, the director now directly owns 31,235 shares of the company's stock, valued at $140,557.50. Learn More on Deepti Jain's trading history.

Who are Treace Medical Concepts' active insiders?

Treace Medical Concepts' insider roster includes Deepti Jain (Director), Richard Mott (Director), Sean Scanlan (SVP), Thomas Timbie (Director), James Treace (Director), John Treace (CEO), and John Treace (Director). Learn More on Treace Medical Concepts' active insiders.

Are insiders buying or selling shares of Treace Medical Concepts?

During the last twelve months, insiders at the sold shares 1 times. They sold a total of 50,000 shares worth more than $398,500.00. The most recent insider tranaction occured on March, 17th when insider Sean F Scanlan sold 50,000 shares worth more than $398,500.00. Insiders at Treace Medical Concepts own 27.7% of the company. Learn More about insider trades at Treace Medical Concepts.

Information on this page was last updated on 3/17/2025.

Deepti Jain Insider Trading History at Treace Medical Concepts

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/10/2024Buy25,000$4.50$112,500.0031,235View SEC Filing Icon  
See Full Table

Deepti Jain Buying and Selling Activity at Treace Medical Concepts

This chart shows Deepti Jain's buying and selling at Treace Medical Concepts by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Treace Medical Concepts Company Overview

Treace Medical Concepts logo
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Read More

Today's Range

Now: $2.74
Low: $2.65
High: $2.79

50 Day Range

MA: $5.08
Low: $2.61
High: $6.95

2 Week Range

Now: $2.74
Low: $2.56
High: $10.79

Volume

733,622 shs

Average Volume

1,250,454 shs

Market Capitalization

$174.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73